Purpose of review 

The current article reviews enhancements to the delivery of glaucoma care that developed in response to the coronavirus disease 19 (COVID-19) pandemic and are likely to persist beyond its resolution.

Recent findings 

Literature from the review period (2020–2021) includes reports highlighting contributions of the ophthalmology community to global health during the pandemic. Glaucoma practices worldwide have instituted more robust infection control measures to mitigate severe acute respiratory syndrome coronavirus 2 transmission in the outpatient setting, and many of these modifications will endure in the post-COVID era. Operational adjustments have led to the provision of more efficient glaucoma care. A hybrid care model involving technician-based diagnostic testing and subsequent virtual consultation with a glaucoma specialist has evolved as a useful adjunct to traditional face-to-face encounters with patients.

Summary 

Glaucoma specialists, patients, and staff have adapted to a ‘new normal’ of glaucoma care delivery during the COVID-19 pandemic. Although innovation has propelled several improvements to glaucoma care during this global health crisis, significant barriers to more widespread implementation of teleglaucoma still exist. Whether, and in what capacity, the pandemic has permanently altered glaucoma practice patterns remains to be seen.

中文翻译：

---

大流行后青光眼护理如何变得更好

 审查目的

本文回顾了为应对冠状病毒病 19 (COVID-19) 大流行而开发的青光眼护理服务的改进，并且可能会持续到问题解决后。

 最近的发现

审查期间（2020-2021）的文献包括强调眼科界在大流行期间对全球健康做出的贡献的报告。世界各地的青光眼实践已经制定了更强有力的感染控制措施，以减轻严重急性呼吸综合征冠状病毒 2 在门诊环境中的传播，其中许多修改将在后新冠时代持续下去。运营调整带来了更有效的青光眼护理。一种混合护理模式，涉及基于技术人员的诊断测试和随后与青光眼专家的虚拟咨询，已发展成为传统面对面与患者接触的有用辅助手段。

 概括

青光眼专家、患者和工作人员已经适应了 COVID-19 大流行期间青光眼护理服务的“新常态”。尽管在这场全球健康危机期间，创新推动了青光眼护理的多项改进，但更广泛实施青光眼治疗的重大障碍仍然存在。这种流行病是否以及以何种方式永久性地改变了青光眼的治疗模式还有待观察。